Your SlideShare is downloading. ×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

European Vaccine Markets

369
views

Published on


0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
369
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Get more info on this report!European Vaccine MarketsNovember 1, 2010Countries covered: EuropeThe European vaccines market has demonstrated growth even through tough economictimes. This has mainly been due to the introduction of vaccines in untapped diseasemarkets and government’s acceptance and willingness to pay for new products. Thishas encouraged market participants to increase spending in research and development.This report, European Vaccine Markets, examines the market for vaccines used inhumans for various types of disease. It covers only commercialized vaccines anddevelopmental vaccines for diseases that are already vaccine-preventable; it does notcover emerging vaccines for diseases that are not currently vaccine-preventable, suchas Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection,ETEC infection, heart attack, Helicobacter pylori infection, multiple sclerosis,Parkinson’s disease, West Nile virus (WNV) infection, etc.; vaccines that address theseconditions are discussed in Kalorama’s new report, “Emerging Vaccines: The WorldMarket.” The report includes vaccine market stats for: Adult Vaccines-Estimates and Forecasts for o Influenza o Pneumococcal o Meningitis/Pneumonia o DTaP o Hepatitis o HPV o Travel and Endemic o Others Pediatric Vaccines-Estimates and Forecasts for: o Haemophilus influenzae type b (Hib) o Pneumococcal infection o Diphtheria o Tetanus o Pertussis (whooping cough) o Hepatitis A and B
  • 2. o Rotavirus o Polio o Measles o Mumps and Rubella o Varicella (chicken pox) o Influenza o Meningitis o Human papillomavirus (HPV) o Combination Vaccines o OthersThe report also contains adult and pediatric vaccine regional market shares for thefollowing countries: United Kingdom Germany Spain France Italy Rest of Europe**In this Kalorama Information Report "Rest of Europe" is broken down in the totalmarket summary (adult and pediatric combined) to include regional market share of thetotal European Vaccine market for Benelux, Scandinavia, Switzerland, Russia, Poland,Balkans, Baltic Countries, Hungary and OtherThe report also includes company market shares for European adult and pediatricvaccine markets, key issues and trend affecting the industry, and detailed profiles ofmajor vaccine competitors, including: Bavarian Nordic A/S Baxter International Crucell Emergent Biosolutions GlaxoSmithKline Novartis Pfizer Inc. Sanofi Pasteur
  • 3. Table of ContentsTABLE OF CONTENTS CHAPTER ONE: EXECUTIVE SUMMARY THE EUROPEAN VACCINES MARKET o Scope and Methodology o Overview o Pediatric Preventative Vaccines Adult Preventative Vaccines Total Market Issues and TrendsCHAPTER TWO: INTRODUCTION TO VACCINES A Brief History: The Development of Vaccines The Immune Response Mechanism of Action Types of Vaccines o Attenuated (Weakened) Live Viruses o Killed (Inactivated) Viruses o Toxoid Vaccines Genetically Engineered/Modified Vaccines o Subunit Vaccines o Conjugate Vaccines o DNA Vaccination Vaccine Approval ProcessCHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES Introduction o United Nations Initiatives Pediatric Vaccine Products o BCG o Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio o Diphtheria o Pertussis o Tetanus o Hepatitis B o Poliomyelitis o Haemophilus Influenzae Type B o Hepatitis A o Measles, Mumps and Rubella
  • 4. o Measles o Mumps o Rubella o Meningococcal Disease o Pneumococcal Conjugate o Rotavirus o Varicella Pediatric Vaccines in Development The European Market for Pediatric Preventive Vaccines o Total European Market Size and Forecast o European Market by Product Type o Haemophilus Influenzae Type B (Hib) o Pneumococcal o DTaP o Hepatitis A & B o Rotavirus o Polio o MMR o Varicella o Influenza o Menigococcal o HPV o Combinations o Others o Major Manufacturer’s Market Share—Pediatric VaccinesCHAPTER FOUR: ADULT PREVENTIVE VACCINES Introduction Adult Vaccine-Preventable Diseases: Facts and Figures Recommendations for Adult Immunization o WHO International Health Regulations Adult Vaccine Products o BCG o Cervical Cancer o Cholera o Diphtheria-Tetanus o Hepatitis o Hepatitis A o Hepatitis B o Influenza o Pneumococcal Disease o Rabies o Shingles o Typhoid Fever Adult Vaccines in Development
  • 5. The European Market for Adult Preventive Vaccines o Total European Market Size and Forecast o European Market by Product Type o Influenza o DTaP Booster o HPV o Hepatitis o Meningitis/Pneumonia o Travel/Endemic Vaccines o Others o Major Manufacturer’s Market Share—Adult VaccinesCHAPTER FIVE: VACCINES MARKET SUMMARY Trends Driving the Vaccines Market Market Size and Forecast Vaccine Sales by Region Vaccine Market CompetitorsCHAPTER SIX: ISSUES AND TRENDS Vaccine Safety o Refusal to Immunize o Obesity o World Health Organization o The Future of Vaccine Safety Vaccine Shortages o Financial incentives o Equitable pricing o Vaccine stockpiles o Smallpox o Tularemia o Viral Hemorrhagic Fevers DNA Vaccination Innovations in Vaccine Delivery Systems o Edible Vaccines o Mucosal Delivery o Intranasal Delivery o Vaccine Patches o Vaccine Chips Innovations in Vaccine Production o Tobacco Plant o Insects o Nanoparticle SystemsCHAPTER SEVEN: COMPANY PROFILES
  • 6. Bavarian Nordic A/S o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial InformationBaxter International o History and Lines of Business o Vaccine Products o Financial InformationCrucell o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial InformationEmergent Biosolutions o History and Lines of Business o Strategic Acquisition and Alliance o Vaccine Products o FinancialGlaxoSmithKline o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial InformationNovartis o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial InformationPfizer Inc. o History and Lines of Business o Strategic alliances o Vaccine Products o Financial InformationSanofi Pasteur o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial Information
  • 7. Available immediately for Online Download athttp://www.marketresearch.com/product/display.asp?productid=2833006US: 800.298.5699UK +44.207.256.3920Intl: +1.240.747.3093Fax: 240.747.3004